What's new

What's new

Human medicines European public assessment report (EPAR): Desloratadine Teva, desloratadine, Date of authorisation: 24/11/2011, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Desloratadine Teva, desloratadine, Date of authorisation: 24/11/2011, Revision: 19, Status: Authorised

24 July 2026

European Medicines Agency’s data protection notice for meeting registration forms via Microsoft Forms

European Medicines Agency’s data protection notice for meeting registration forms via Microsoft Forms

24 July 2026

European Medicines Agency’s data protection notice for conducting surveys via Microsoft Forms

European Medicines Agency’s data protection notice for conducting surveys via Microsoft Forms

24 July 2026

European Medicines Agency’s data protection notice for conducting surveys via EUSurvey

European Medicines Agency’s data protection notice for conducting surveys via EUSurvey

24 July 2026

European Medicines Agency’s data protection notice for meeting registration forms via EUSurvey

European Medicines Agency’s data protection notice for meeting registration forms via EUSurvey

24 July 2026

List of changes to combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animal and humans to veterinary medicinal products for 2025

List of changes to combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animal and humans to veterinary medicinal products for 2025

24 July 2026

Vyvgart

Vyvgart

24 July 2026

Combined VeDDRA list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products

Combined VeDDRA list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products

24 July 2026

Antimicrobial Sales and Use (ASU) Platform: Release notes

Antimicrobial Sales and Use (ASU) Platform: Release notes

24 July 2026

SPOR and XEVMPD status update webinar - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2026, 10:00 (CEST) to 8 July 2026, 12:30 (CEST)

SPOR and XEVMPD status update webinar - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2026, 10:00 (CEST) to 8 July 2026, 12:30 (CEST)

24 July 2026